Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4207934
Max Phase: Preclinical
Molecular Formula: C23H17N3O4
Molecular Weight: 399.41
Molecule Type: Small molecule
Associated Items:
ID: ALA4207934
Max Phase: Preclinical
Molecular Formula: C23H17N3O4
Molecular Weight: 399.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](Oc1ccccc1O)C(=O)Nc1ccc2oc(-c3ccc(C#N)cc3)nc2c1
Standard InChI: InChI=1S/C23H17N3O4/c1-14(29-21-5-3-2-4-19(21)27)22(28)25-17-10-11-20-18(12-17)26-23(30-20)16-8-6-15(13-24)7-9-16/h2-12,14,27H,1H3,(H,25,28)/t14-/m0/s1
Standard InChI Key: FPDXMBGYKQBGQY-AWEZNQCLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 399.41 | Molecular Weight (Monoisotopic): 399.1219 | AlogP: 4.48 | #Rotatable Bonds: 5 |
Polar Surface Area: 108.38 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.91 | CX Basic pKa: 0.10 | CX LogP: 4.22 | CX LogD: 4.22 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.51 | Np Likeness Score: -1.51 |
1. Chacko S, Boshoff HIM, Singh V, Ferraris DM, Gollapalli DR, Zhang M, Lawson AP, Pepi MJ, Joachimiak A, Rizzi M, Mizrahi V, Cuny GD, Hedstrom L.. (2018) Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents., 61 (11): [PMID:29746130] [10.1021/acs.jmedchem.7b01839] |
Source(1):